These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36346060)

  • 1. Prognostic Value of Hepatic Native T1 and Extracellular Volume Fraction in Patients with Pulmonary Arterial Hypertension.
    Guo J; Wang L; Wang J; Wan K; Gong C; Chen X; Guo J; Xu Y; He J; Yin L; Pu S; Wen B; Chen C; Han Y; Chen Y
    J Am Heart Assoc; 2022 Nov; 11(22):e026254. PubMed ID: 36346060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of right ventricular native T1 mapping in pulmonary arterial hypertension.
    Asano R; Ogo T; Morita Y; Kotoku A; Aoki T; Hirakawa K; Nakayama S; Ueda J; Tsuji A; Waddingham MT; Ohta Y; Fukuda T; Ohta-Ogo K; Ishibashi-Ueda H; Noguchi T; Yasuda S
    PLoS One; 2021; 16(11):e0260456. PubMed ID: 34843578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic significance of cardiovascular magnetic resonance native myocardial T1 mapping in patients with pulmonary hypertension.
    Saunders LC; Johns CS; Stewart NJ; Oram CJE; Capener DA; Puntmann VO; Elliot CA; Condliffe RC; Kiely DG; Graves MJ; Wild JM; Swift AJ
    J Cardiovasc Magn Reson; 2018 Dec; 20(1):78. PubMed ID: 30501639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension.
    Patel RB; Li E; Benefield BC; Swat SA; Polsinelli VB; Carr JC; Shah SJ; Markl M; Collins JD; Freed BH
    ESC Heart Fail; 2020 Feb; 7(1):253-263. PubMed ID: 31903694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular Volume Associates With Outcomes More Strongly Than Native or Post-Contrast Myocardial T1.
    Treibel TA; Fridman Y; Bering P; Sayeed A; Maanja M; Frojdh F; Niklasson L; Olausson E; Wong TC; Kellman P; Miller CA; Moon JC; Ugander M; Schelbert EB
    JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):44-54. PubMed ID: 31103587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of heart failure in hemodialysis-dependent end-stage renal disease patients with myocardial fibrosis quantification by extracellular volume on cardiac magnetic resonance imaging.
    Xu HY; Yang ZG; Zhang Y; Peng WL; Xia CC; Li ZL; He Y; Xu R; Rao L; Peng Y; Li YM; Gao HL; Guo YK
    BMC Cardiovasc Disord; 2020 Jan; 20(1):12. PubMed ID: 31924159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse myocardial fibrosis and the prognosis of heart failure with reduced ejection fraction in Chinese patients: a cohort study.
    Li F; Xu M; Fan Y; Wang Y; Song Y; Cui X; Fu M; Qi B; Han X; Zhou J; Ge J
    Int J Cardiovasc Imaging; 2020 Apr; 36(4):671-689. PubMed ID: 31893323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of Pulmonary Transit Time by Cardiac Magnetic Resonance on Mortality and Heart Failure Hospitalization in Patients With Advanced Heart Failure and Reduced Ejection Fraction.
    Houard L; Amzulescu MS; Colin G; Langet H; Militaru S; Rousseau MF; Ahn SA; Vanoverschelde JJ; Pouleur AC; Gerber BL
    Circ Cardiovasc Imaging; 2021 Jan; 14(1):e011680. PubMed ID: 33438438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure.
    Puntmann VO; Carr-White G; Jabbour A; Yu CY; Gebker R; Kelle S; Hinojar R; Doltra A; Varma N; Child N; Rogers T; Suna G; Arroyo Ucar E; Goodman B; Khan S; Dabir D; Herrmann E; Zeiher AM; Nagel E;
    JACC Cardiovasc Imaging; 2016 Jan; 9(1):40-50. PubMed ID: 26762873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncontrast Myocardial T1 Mapping by Cardiac Magnetic Resonance Predicts Outcome in Patients With Aortic Stenosis.
    Lee H; Park JB; Yoon YE; Park EA; Kim HK; Lee W; Kim YJ; Cho GY; Sohn DW; Greiser A; Lee SP
    JACC Cardiovasc Imaging; 2018 Jul; 11(7):974-983. PubMed ID: 29153562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial Native T
    Omori T; Nakamori S; Fujimoto N; Ishida M; Kitagawa K; Ichikawa Y; Kumagai N; Kurita T; Imanaka-Yoshida K; Hiroe M; Sakuma H; Ito M; Dohi K
    JACC Cardiovasc Imaging; 2020 Oct; 13(10):2117-2128. PubMed ID: 32771571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular volume fraction assessed using cardiovascular magnetic resonance can predict improvement in left ventricular ejection fraction in patients with dilated cardiomyopathy.
    Inui K; Asai K; Tachi M; Yoshinaga A; Izumi Y; Kubota Y; Murai K; Tsukada YT; Amano Y; Kumita S; Shimizu W
    Heart Vessels; 2018 Oct; 33(10):1195-1203. PubMed ID: 29560528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of extracellular volume fraction by cardiac magnetic resonance imaging and QRS duration for the risk stratification for patients with non-ischemic dilated cardiomyopathy.
    Kodama S; Kato S; Hayakawa K; Azuma M; Kagimoto M; Iguchi K; Fukuoka M; Fukui K; Iwasawa T; Utsunomiya D; Kosuge M; Kimura K; Tamura K
    Heart Vessels; 2020 Oct; 35(10):1439-1445. PubMed ID: 32417957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reference values of myocardial structure, function, and tissue composition by cardiac magnetic resonance in healthy African-Americans at 3T and their relations to serologic and cardiovascular risk factors.
    Liu CY; Bluemke DA; Gerstenblith G; Zimmerman SL; Li J; Zhu H; Lai S; Lai H
    Am J Cardiol; 2014 Sep; 114(5):789-795. PubMed ID: 25037675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction.
    Mascherbauer J; Marzluf BA; Tufaro C; Pfaffenberger S; Graf A; Wexberg P; Panzenböck A; Jakowitsch J; Bangert C; Laimer D; Schreiber C; Karakus G; Hülsmann M; Pacher R; Lang IM; Maurer G; Bonderman D
    Circ Cardiovasc Imaging; 2013 Nov; 6(6):1056-65. PubMed ID: 24036385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Pulmonary Transit Time and Pulmonary Blood Volume Estimation Using Myocardial Perfusion CMR.
    Seraphim A; Knott KD; Menacho K; Augusto JB; Davies R; Pierce I; Joy G; Bhuva AN; Xue H; Treibel TA; Cooper JA; Petersen SE; Fontana M; Hughes AD; Moon JC; Manisty C; Kellman P
    JACC Cardiovasc Imaging; 2021 Nov; 14(11):2107-2119. PubMed ID: 34023269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of Hepatic T1-Mapping and Extracellular Volume Quantification on Routine Cardiac Magnetic Resonance Imaging in Patients with Infiltrative and Systemic Disorders.
    Dolan RS; Stillman AE; Davarpanah AH
    Acad Radiol; 2022 Apr; 29 Suppl 4():S100-S109. PubMed ID: 34702675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of cardiovascular magnetic resonance imaging measurements corrected for age and sex in idiopathic pulmonary arterial hypertension.
    Swift AJ; Rajaram S; Campbell MJ; Hurdman J; Thomas S; Capener D; Elliot C; Condliffe R; Wild JM; Kiely DG
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):100-6. PubMed ID: 24275955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between cardiovascular magnetic resonance imaging measurement of extracellular volume fraction and clinical outcomes in adults with repaired tetralogy of Fallot.
    Hanneman K; Crean AM; Wintersperger BJ; Thavendiranathan P; Nguyen ET; Kayedpour C; Wald RM
    Eur Heart J Cardiovasc Imaging; 2018 Jul; 19(7):777-784. PubMed ID: 29045596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T1 Mapping by CMR Imaging: From Histological Validation to Clinical Implication.
    Kammerlander AA; Marzluf BA; Zotter-Tufaro C; Aschauer S; Duca F; Bachmann A; Knechtelsdorfer K; Wiesinger M; Pfaffenberger S; Greiser A; Lang IM; Bonderman D; Mascherbauer J
    JACC Cardiovasc Imaging; 2016 Jan; 9(1):14-23. PubMed ID: 26684970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.